CHF Solutions, Inc. to Present at the LD Micro 10th Annual Main Event on December 5, 2017

EDEN PRAIRIE, Minn., Nov. 30, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. CHFS announced today that Claudia Drayton, Chief Financial Officer will be a featured presenter at the LD Micro 10th Annual Main Event on Tuesday, December 5, 2017 at 9:30 AM Pacific Time. The conference is being held at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Ms. Drayton will provide an overview of the company's business model and growth strategy and will be available for one-on-one meetings.

About CHF Solutions

CHF Solutions, Inc. CHFS is a medical device company focused on commercializing the Aquadex FlexFlow system for Aquapheresis® therapy. The Aquadex FlexFlow system, is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. All treatments must be administered by a healthcare provider, under physician prescription, both of whom having received training in extracorporeal therapies. The company's objective is to improve the quality of life for patients with heart failure and related conditions. CHF Solutions is a Delaware corporation headquartered in Minneapolis, Minnesota with wholly owned subsidiaries in Australia and Ireland. The company has been listed on the NASDAQ Capital Market since February 2012.

For further information, please contact:

Claudia Napal Drayton
Chief Financial Officer 
CHF Solutions, Inc.
T: +1-952-345-4205

Investor Relations 
CHF Solutions, Inc. 
ir@chf-solutions.com

-or-

Bret Shapiro
CORE IR
516 222 2560
brets@coreir.com
www.coreir.com